Endocervical vs. Endometrial Adenocarcinoma
Endocervical and endometrial adenocarcinomas may be morphologically indistinguishable morphologically. The question often comes as to whether a case represents an endometrial adenocarcinoma involving the cervix, or and endocervical adenocarcinoma involving the endometrium. The following antibodies may be helpful in such circumstances:
|
|
Endocervical
Adenocarcinoma
|
|
|
Negative (7-8%+)
|
Positive (70-93%)
|
|
|
Positive (65-95%)
|
Usually Negative
|
|
|
Negative (4-20%+, 38% weak)
|
Strong Positive (67-90%)
|
|
|
Strong & Diffuse Positive (90-100%)
|
Patchy Positive cells (~35%)
|
|
|
HPV
|
Positive (67%)
|
Negative
|
References
AJSP 2002;26:998
“Endocervical vs. Endometrial Adenocarcinoma: Update on Useful Immunohistochemical Markers.” RT Miller,The Focus ProPath Immunohistochemistry.” April 2003.